CSGALNACT2 Antikörper (Middle Region)
Kurzübersicht für CSGALNACT2 Antikörper (Middle Region) (ABIN453587)
Target
Alle CSGALNACT2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- This antibody reacts to CSGALNACT2.
-
Aufreinigung
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide selected from the Center region of human CSGALNACT2
-
-
-
-
Applikationshinweise
-
ELISA: 1/1,000. Western blotting: 1/100 - 1/500.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- CSGALNACT2 (Chondroitin Sulfate N-Acetylgalactosaminyltransferase 2 (CSGALNACT2))
-
Andere Bezeichnung
- CSGALNACT2
-
Hintergrund
- Transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of glucuronic acid (GlcUA). It is required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains.Synonyms: 4-N-acetylgalactosaminyltransferase 2, Beta4GalNAcT-2, CHGN2, Chondroitin beta-1, Chondroitin sulfate N-acetylgalactosaminyltransferase 2, GALNACT2, GalNAcT-2
-
Gen-ID
- 55454
-
NCBI Accession
- NP_061060
-
UniProt
- Q8N6G5
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-